Top Markets
#1 Tutorial Tutorial +32.13%
#2 Official Trump Official Trump +30.85%
#3 Siacoin Siacoin +22.01%
#4 Mubarak Mubarak +20.77%
#5 EXOD EXOD +18.93%
#6 MowCat MowCat +18.78%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +18.51%
#8 Pump.fun Pump.fun +18.05%
#9 Unit Pump Unit Pump +17.74%
#10 Melania Meme Melania Meme +16.61%
Coin of the day
Tutorial Tutorial
Settings
Language
ENGLISH
Currency
USD
Theme
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rank in Stocks #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Share Price
$0.04959193
Last synced: 2025-03-17
Market Cap
$79.94M
Change (1 day)
13.49%
Change (1 year)
0.00%
Country
SE
Trade Abliva AB (publ) (ABLI)

Category

Healthcare
EPS for Abliva AB (publ) (ABLI)
EPS as of 2026 TTM: 0
According to Abliva AB (publ) latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Abliva AB (publ) from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH